Overview
?
Zhi Hui Lin
See more contacts
Scientific Research and Development Services
,
Other Professional, Scientific, and Technical Services
,
Drugs and Druggists' Sundries Merchant Wholesalers
,
Commercial physical research
,
Commercial nonphysical research
See All Industries Pharmaceuticals
See Fewer Industries
See All Industries Pharmaceuticals
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
$1.02 million
Actual
-29.9%
$633
DEC
?
?
GreTai:4172
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2023 (12 month period) in USD
Annual Revenue 2024
$1.02 million
USD
Actual
1 USD = 31.6446 TWD
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | -$2 | -$2 | -$3 |
| Net Investing Cash | -$0 | -$2 | $1 |
| Net Financing Cash | $7 | $3 | $1 |
| Net Change in Cash | $4 | -$0 | -$2 |
| Cash at Beginning of Period | $1 | $1 | $3 |
| Cash at End of Period | $5 | $1 | $1 |
| Capital Expenditure | -$0 | -$0 | -$0 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $5 | $1 | $1 |
| Accounts Receivable | $0 | $0 | $ |
| Inventories | $1 | $1 | $1 |
| Other Current Assets | $4 | $4 | $2 |
| Asset Summary | |||
| Total Current Assets | $10 | $6 | $4 |
| Tangible Fixed Assets | $0 | $0 | $1 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $633 | $524 | $489 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $1 |
| Other Current Liabilities | $1 | $0 | $0 |
| Liability Summary | |||
| Total Current Liabilities | $1 | $1 | $1 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $0 | $0 |
| Total Liabilities | $1 | $2 | $2 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $34 | $30 | $27 |
| Retained Earnings | -$18 | -$16 | -$14 |
| Equity Summary | |||
| Total Equity | $19 | $15 | $14 |
| Shares Outstanding | 107,580,800 | 95,644,718 | 88,643,392 |